Abstract:Identifying drug phenotypic effects, including therapeutic effects and adverse drug reactions (ADRs), is an inseparable part for evaluating the potentiality of new drug candidates (NDCs). However, current computational methods for predicting phenotypic effects of NDCs are mainly based on the overall structure of an NDC or a related target. These approaches often lead to inconsistencies between the structures and functions and limit the prediction space of NDCs. In this study, first, we constructed quantitative associations of substructure-domain, domain-ADR, and domain-ATC (Anatomical Therapeutic Chemical Classification System code) through L1LOG and L1SVM machine learning models. These associations represent relationships between phenotypes (ADRs and ATCs) and local structures of drugs and proteins. Then, based on these established associations, substructure-phenotype relationships were constructed which were utilized to quantify drug-phenotype relationships. Thus, this approach could achieve high-throughput and effective evaluations of the druggability of NDCs by referring to the established substructure-phenotype relationships and structural information of NDCs without additional prior knowledge. Using this computational pipeline, 83,205 drug-ATC relationships (including 1,479 drugs and 178 ATCs) and 306,421 drug-ADR relationships (including 1,752 drugs and 454 ADRs) were predicted in total. The prediction results were validated at four levels: five-fold cross validation, public databases, literature, and molecular docking. Furthermore, three case studies demonstrated the feasibility of our method. 79 ATCs and 269 ADRs were predicted to be related to Maraviroc, an approved drug, including the existing antiviral effect in clinical use. Additionally, we also found risk substructures of severe ADRs, for example, SUB215 (>= 1, saturated or only aromatic carbon ring size 7) can result in shock. And we analyzed the mechanism of action (MOA) of interested drugs based on the established drug-substructure-domain-protein associations. In a word, this approach through establishing drug-substructure-phenotype relationships can achieve quantitative prediction of phenotypes for a given NDC or drug without any prior knowledge except its structure information. Using that way, we can directly obtain the relationships between substructure and phenotype of a compound, which is more convenient to analyze the phenotypic mechanism of drugs and accelerate the process of rational drug design.

Concept-Based Semi-Automatic Classification of Drugs

A hybrid method for prediction and repositioning of drug Anatomical Therapeutic Chemical classes.

Similarity-based prediction for Anatomical Therapeutic Chemical classification of drugs by integrating multiple data sources

Network predicting drug's anatomical therapeutic chemical code.

ATC-NLSP: Prediction of the Classes of Anatomical Therapeutic Chemicals Using a Network-Based Label Space Partition Method.

Predicting Combinative Drug Pairs Via Multiple Classifier System with Positive Samples Only

Drug Repositioning by Prediction of Drug's Anatomical Therapeutic Chemical Code Via Network-Based Inference Approaches.

Inferring Anatomical Therapeutic Chemical (ATC) Class of Drugs Using Shortest Path and Random Walk with Restart Algorithms

A Convolutional Neural Network and Graph Convolutional Network-Based Method for Predicting the Classification of Anatomical Therapeutic Chemicals.

A Novel Approach Based on Deep Residual Learning to Predict Drug's Anatomical Therapeutic Chemical Code.

MultiCon: A Semi-Supervised Approach for Predicting Drug Function from Chemical Structure Analysis

Deep fusion learning facilitates anatomical therapeutic chemical recognition in drug repurposing and discovery

Integrated Multi-Class Classification and Prediction of GPCR Allosteric Modulators by Machine Learning Intelligence

Chemical Medicine Classification Through Chemical Properties Analysis.

Identifying the Kind Behind SMILES-anatomical Therapeutic Chemical Classification Using Structure-Only Representations.

RNPredATC: A Deep Residual Learning-Based Model with Applications to the Prediction of Drug-ATC Code Association.

Prediction of Drug Indications Based on Chemical Interactions and Chemical Similarities.

Classification and its applications for drug-target interaction identification

A Review of Deep Learning-Based Approaches for Detection and Diagnosis of Diverse Classes of Drugs

Computational Prediction of Drug Phenotypic Effects Based on Substructure-Phenotype Associations.

Assessing the anticholinergic cognitive burden classification of putative anticholinergic drugs using drug properties